04 Cardiovascular diseases Hypertension non clinical

Cardiovascular diseases: Hypertension
Non Clinical
Machinery/Device
1. Abu Bakar I, Shuaib IL, Mohd Ariff AR, et al. Diagnostic cerebral angiography in spontaneous
intracranial haemorrhage: a guide for developing countries. Asian J Surg 2005;28(1):1-6.
2. Aris IB, Wagie AA, Mariun NB, et al. An internet-based blood pressure monitoring system for
patients. J Telemed Telecare 2001;7(1):51-53.
3. Mat Nor K, Azad Hassan A, Gobal S, et al. Bilateral traumatic renal artery dissection and
thrombosis complicated by hypertension and renal failure. Biomed Imaging Interv J
2013;9(3):e15 http://www.biij.org/2013/3/e15/e15.pdf.
4. Mohamed AL, Katiman E, Hassan JA. Ambulatory blood pressure monitoring profile as a
useful prognostic tool in patients with primary hypertension. Malays J Med Sci
2003;10(2):76-83
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561891/pdf/mjms-10-2-076.pdf.
5. Reidpath DD, Ling ML, Yasin S, et al. Community-based blood pressure measurement by nonhealth workers using electronic devices: a validation study. Glob Health Action 2012;5:14876.
6. Shariati NH, Zahedi E, Jajai HM. Classification of vascular function in upper limb using
bilateral photoplethysmographic signals. Physiol Meas 2008;29(3):365-374.
7. Suresh RL, Guinane M, Ainley C. The use of endoscopic ultrasound and intravenous secretin
as an investigative tool to aid diagnosis in pancreatic sphincter hypertension. Med J Malaysia
2001;56(3):382-385


http://www.e-

mjm.org/2001/v56n3/Pancreatic_Sphincter_Hypertension.pdf.
8. Teh LK, Zahri MK, Zakaria ZA, et al. Mutational analysis of CYP2C8 in hypertensive patients
using denaturing high performance liquid chromatography. J Clin Pharm Ther
2010;35(6):723-728.

Laboratory based
1. Aidiahmad D. Interaction Between The Renin Angiotensin System And A1-Adrenergic
Receptors At The Renal Resistance Vessels In Diabetes Mellitus And Hypertension. 2007;.
2. Al-Mahmood AK, Ismail AA, Rashid FA, et al. Mixed hyperlipidemia in non-obese Malay
subjects: its relationship with insulin sensitivity. NCD Malaysia 2005;4(3):13-18
http://www.dph.gov.my/ncd/bulletin/July_Sept05/06.Mixed%20Hyperlipidemia.pdf.

3. Al-Mahmood AK, Rashid FA, Ismail AA. Isolated hypercholesterolemia: its relationship with
insulin sensitivity. NCD Malaysia 2005;4(4):22 -27
http://www.dph.gov.my/ncd/bulletin/Oct_Dec05/07.Isolated.pdf.
4. Azizi A, Awang MZ, Rafidah Hanim M. Plasma total homocysteine concentration is related to
insulin level in hypertensive subjects. International Medical Journal (IIUM) 2006;5(1)
http://www.e-imj.com/Vol5-No1/Vol5-No1-B6.htm.

5. Azizi A, Rafidah Hanim M, Tariq AR. Effects sof irbesartan on beta-cell function and insulin
sensitivity in hypertensive and hypertensive diabetic subjects. International Medical Journal
(IIUM) 2005;4(1) http://www.e-imj.com/Vol4-No1/Vol4-No1-B15.htm.
6. Azizi A, Tariq AR. Effects of irbesartan, an angiotensin receptor blocker, on glucose tolerance
in hypertensive patients: preliminary findings. International Medical Journal (IIUM) 2004;3(2)
http://www.e-imj.com/Vol3-No2/Vol3-No2-B1.htm.
7. Emilia A, Atif AB, Zahiri M, et al. Angiotensin converting enzyme(ACE) I/D polymorphism in
obesity. Genetik 2012;19(Jan & Jul):50
http://www.persatuangenetikmalaysia.com/bulletinjan12.pdf.
8. Erejuwa OO, Sulaiman SA, Wahab MS, et al. Differential responses to blood pressure and
oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously
hypertensive rats: effects of antioxidant (honey) treatment. Int J Mol Sci 2011;12(3):18881907.
9. Ghazali DM, Rehman A, Rahman AR. Candidate gene polymorphisms and their association
with hypertension in Malays. Clin Chim Acta 2008;388(1-2):46-50.
10. Gurpreet K, Tee GH, Karuthan C. Evaluation of the accuracy of the Omron HEM-907 blood
pressure

device.

Med


J

Malaysia

2008;63(3):239-243

http://www.e-

mjm.org/2008/v63n3/Omron_Hem_907.pdf.
11. Ibrahim IA, Al-Joudi FS. The angiotensin-converting enzyme inhibitor, captopril, alters some
biochemical laboratory measurements in vitro. Malaysian Journal of Biochemistry and
Molecular Biology 2009;17(1):20-22
http://myais.fsktm.um.edu.my/8442/1/2009_Vol17_No1_Article5.pdf.
12. Lim CP, Loo AV, Khaw KW, et al. Plasma, aqueous and vitreous homocysteine levels in
proliferative diabetic retinopathy. Br J Ophthalmol 2012;96(5):704-707.
13. Loh SP, Hadira O. In vitro inhibitory potential of selected Malaysian plants against key
enzymes involved in hyperglycemia and hypertension. Malays J Nutr 2011;17(1):77-86.

14. Lye HS, Kuan CY, Ewe JA, et al. The improvement of hypertension by probiotics: effects on

cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10(9):3755-3775
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769158/.
15. Nazratun N, Mahmood AA, Kuppusamy UR, et al. Diabetes mellitus exacerbates advanced
glycation end product accumulation in the veins of end-stage renal failure patients. Vasc Med
2006;11(4):245-250.
16. Norsham J, Azmani SM, Roslan H, et al. Plasma BNP level as marker for early detection of
heart failure in primary hypertensive patients. Malaysian Journal of Medicine and Health
Sciences 2012;8(1):13-19
http://medic.upm.edu.my/images/stories/journal/VOL8NO1_JANUARI2012.pdf.
17. Ong HT. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk
patient. QJM 2005;98(8):599-614.
18. Ramachandran V, Ismail P, Stanslas J, et al. Analysis of renin-angiotensin aldosterone system
gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects.
Cardiovasc Diabetol 2009;8:11-2840-8-11.
19. Ramachandran V, Ismail P, Stanslas J, et al. Association of insertion/deletion polymorphism of
angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes
mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst 2008;9(4):208-214.
20. Ramirez SP, McClellan W, Port FK, et al. Risk factors for proteinuria in a large, multiracial,
southeast Asian population. J Am Soc Nephrol 2002;13(7):1907-1917.
21. Rehman A, Ismail SB, Naing L, et al. Reduction in arterial stiffness with angiotensin II

antagonism and converting enzyme inhibition. A comparative study among malay
hypertensive subjects with a known genetic profile. Am J Hypertens 2007;20(2):184-189.
22. Rehman A, Rasool AH, Naing L, et al. Influence of the Angiotensin II type I receptor gene
1166A > C polymorphism on BP and aortic pulse wave velocity among Malays. Ann Hum
Genet 2007;71(Pt 1):86-95.
23. Rosnani H, Tariq AR. Effect of rilmenidine on hypertension, biochemical risk factors of
cardiovascular disease, and sexual function. International Medical Journal (IIUM)
2003;2(2)http://www.e-imj.com/Vol2-No2/Vol2-No2-D2.htm
24. Say YH, Ling KH, Duraisamy G, et al. Angiotensinogen M235T gene variants and its
association with essential hypertension and plasma renin activity in Malaysian subjects: a
case control study. BMC Cardiovasc Disord 2005;5(1):7.

25. Vasudevan R, Ismail P, Stanslas J, et al. Association of insertion/deletion polymorphism of
alpha-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus
in Malaysian subjects. Int J Biol Sci 2008;4(6):362-367.